THQ-50480-89358
4 vaccinations
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 990 / WA
- Registered
- 2022-06-24
- Relationship
- Child or adolescent in my care
- Guardian
- 282-21194-29165
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-14
Dose 1 — Pfizer-BioNTech
-
2021-06-04
Dose 2 — Pfizer-BioNTech
-
2022-01-07
Dose 3 — ModernaCo-administered: Flu
-
2022-06-24
Registered in v-safe
-
2022-07-08
Survey response — 6 months, dose 3, dependentMedDRA: Chills, Cough, Fatigue, Headache, Oropharyngeal pain, Pain, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Cough, sore throat, runny nose, moderate fatigue, body aches, headache, chillsMedDRA releases: 2024-11 · check-in free text available
-
2022-09-21
Dose 4 — Pfizer-BioNTech
- 2023-01-07
- 2023-03-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-14 | Pfizer-BioNTech | No |
| 2 | 2021-06-04 | Pfizer-BioNTech | No |
| 3 | 2022-01-07 | Moderna | Flu |
| 4 | 2022-09-21 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 3, dependent
Symptoms: Cough, sore throat, runny nose, moderate fatigue, body aches, headache, chills
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release